ONO-4538 + ONO-4538
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Non-small Cell Lung Cancer (NSCLC)
Conditions
Advanced Non-small Cell Lung Cancer (NSCLC)
Trial Timeline
Jun 1, 2014 → Feb 1, 2021
NCT ID
NCT02175017About ONO-4538 + ONO-4538
ONO-4538 + ONO-4538 is a phase 2 stage product being developed by Ono Pharmaceutical for Advanced Non-small Cell Lung Cancer (NSCLC). The current trial status is completed. This product is registered under clinical trial identifier NCT02175017. Target conditions include Advanced Non-small Cell Lung Cancer (NSCLC).
What happened to similar drugs?
16 of 20 similar drugs in Advanced Non-small Cell Lung Cancer (NSCLC) were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02175017 | Phase 2 | Completed |
Competing Products
20 competing products in Advanced Non-small Cell Lung Cancer (NSCLC)